ES2126147T3 - Granulado efervescente y procedimiento para su preparacion. - Google Patents

Granulado efervescente y procedimiento para su preparacion.

Info

Publication number
ES2126147T3
ES2126147T3 ES94927594T ES94927594T ES2126147T3 ES 2126147 T3 ES2126147 T3 ES 2126147T3 ES 94927594 T ES94927594 T ES 94927594T ES 94927594 T ES94927594 T ES 94927594T ES 2126147 T3 ES2126147 T3 ES 2126147T3
Authority
ES
Spain
Prior art keywords
pct
calcium carbonate
acid
citric acid
granulated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94927594T
Other languages
English (en)
Inventor
Gerhard Gergely
Thomas Gergely
Irmgard Gergely
Stefan Gergely
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2126147T3 publication Critical patent/ES2126147T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007Effervescent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

EL MATERIAL EFERVESCENTE GRANULADO PARA UN APREPARACION FARMACEUTICA CONTIENE CARBONATO CALCICO Y ACIDO CITRICO, DONDE DEL 5 AL 20 % DE LAS PARTES EN PESO DEL ACIDO NECESARIAS PARA REACCIONAR CON EL CARBONATO CALCICO SON REEMPLAZADAS POR AL MENOS UNO DE LOS SIGUIENTES COMPONENTES: ACIDO MALICO, ACIDO GLUCONICO Y ACIDO LACTICO ASI COMO SUS SALES (PREFERIBLEMENTE ACIDAS). EL ACIDO CITRICO Y EL CARBONATO CALCICO SON GRANULADOS CON UNA REACCION PARCIAL, Y EN CADA CASO AL MENOS UNA PARTE DEL COMPUESTO QUE SUSTITUYE PARCIALMENTE AL ACIDO CITRICO TAMBIEN ESTA GRANULADO EN FORMA SOLIDA Y EN POLVO JUNTO CON EL ACIDO CITRICO Y EL CARBONATO CALCICO Y/O DISUELTO EN UN LIQUIDO DE GRANULACION O EN UNA SOLUCION TAMPON.
ES94927594T 1993-09-09 1994-09-09 Granulado efervescente y procedimiento para su preparacion. Expired - Lifetime ES2126147T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH270093 1993-09-09

Publications (1)

Publication Number Publication Date
ES2126147T3 true ES2126147T3 (es) 1999-03-16

Family

ID=4239630

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94927594T Expired - Lifetime ES2126147T3 (es) 1993-09-09 1994-09-09 Granulado efervescente y procedimiento para su preparacion.

Country Status (17)

Country Link
US (1) US5759575A (es)
EP (1) EP0717614B1 (es)
KR (1) KR100351748B1 (es)
CN (1) CN1060037C (es)
AT (1) ATE173614T1 (es)
AU (1) AU677432B2 (es)
BR (1) BR9407444A (es)
CA (1) CA2171435C (es)
CZ (1) CZ285475B6 (es)
DE (1) DE59407351D1 (es)
ES (1) ES2126147T3 (es)
FI (1) FI116449B (es)
HU (1) HU221814B1 (es)
PL (1) PL176005B1 (es)
RU (1) RU2153330C2 (es)
SK (1) SK280055B6 (es)
WO (1) WO1995007070A1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19814257A1 (de) 1998-03-31 1999-10-07 Asta Medica Ag Brauseformulierungen
DE19822036A1 (de) * 1998-05-15 1999-11-18 Bayer Ag Brausezubereitungen
EP1004292B1 (en) * 1998-11-23 2003-08-13 E-PHARMA TRENTO S.p.A. Method for preparing an effervescent granulate
US6264984B1 (en) 1999-12-06 2001-07-24 Bristol-Myers Squibb Company Effervescent histamine H2 antagonist composition
EP1417958A1 (en) * 2002-11-08 2004-05-12 Pari GmbH Wet granulation process
JP2008500288A (ja) * 2004-05-28 2008-01-10 イメイジノット ピーティーワイ エルティーディー 経口治療用化合物の供給系
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
US20070003611A1 (en) * 2005-06-29 2007-01-04 Sung-Tsuen Liu Novel method of granulating calcium carbonate and products provided therefrom
CN1292756C (zh) * 2005-08-08 2007-01-03 李海涛 一种补充人体营养元素的泡腾片制剂及其制备方法
EP3449928A1 (en) * 2005-11-28 2019-03-06 Imaginot Pty Ltd. Oral therapeutic compound delivery system
US7273521B1 (en) 2006-04-28 2007-09-25 J.M. Huber Corporation Method of producing granulated calcium carbonate/calcium phosphate composite materials with very high calcium to phosphate mole ratios
TR200908237A2 (tr) 2009-11-02 2011-05-23 Bi̇lgi̇ç Mahmut Kalsiyum ve D vitamini içeren farmasötik bileşimler.
CN101721387B (zh) * 2009-12-24 2013-01-02 山东达因海洋生物制药股份有限公司 一种碳酸钙泡腾剂及其制备方法
FR2992219B1 (fr) * 2012-06-22 2014-07-11 Aditec Lab Composition pour le traitement de l'hypocalcemie chez les ruminants
US20150289554A1 (en) * 2012-10-25 2015-10-15 Otc Nutrition Llc Fast Dissolving Solid Calcium Mineral Supplement Compositions and Processing Making
CH710361B1 (de) * 2014-11-12 2018-12-28 Laboratoires Biofar Sarl Natrium-Ion-freie Brausetablette oder Brausepulver mit hohem Calcium-Ion-Gehalt (CaCO3).
IT201700099708A1 (it) 2017-09-06 2019-03-06 Abiogen Pharma Spa Composizione per l’integrazione di calcio
IT201700099690A1 (it) * 2017-09-06 2019-03-06 Abiogen Pharma Spa Composizione per l’integrazione di calcio

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6092378A (ja) * 1983-09-28 1985-05-23 ゲルハルト・ゲルゲリー 起泡剤およびその製造方法
DE3627475A1 (de) * 1986-06-26 1988-01-14 Gergely Gerhard Verfahren zum herstellen eines brausegranulates, danach hergestelltes brausegranulat sowie dessen verwendung
US4783331A (en) * 1987-06-29 1988-11-08 Miles Inc. Method for solubilization of aspartame in effervescent aqueous systems; and composition
ATE128027T1 (de) * 1991-07-01 1995-10-15 Gergely Gerhard Lutsch- oder kautablette.
AU4597293A (en) * 1992-06-30 1994-01-24 Procter & Gamble Company, The Effervescent calcium supplements
DE69303618T2 (de) * 1992-10-21 1996-11-07 Procter & Gamble Lagerfähige, kalziumzusatzenthaltende getränkekonzentrate und sirup

Also Published As

Publication number Publication date
PL176005B1 (pl) 1999-03-31
HU221814B1 (hu) 2003-01-28
HUT74520A (en) 1997-01-28
KR960703566A (ko) 1996-08-31
PL313479A1 (en) 1996-07-08
ATE173614T1 (de) 1998-12-15
CZ65296A3 (en) 1996-06-12
FI116449B (fi) 2005-11-30
EP0717614A1 (de) 1996-06-26
AU677432B2 (en) 1997-04-24
WO1995007070A1 (de) 1995-03-16
CA2171435C (en) 2005-04-05
HU9600588D0 (en) 1996-05-28
CA2171435A1 (en) 1995-03-16
RU2153330C2 (ru) 2000-07-27
CN1060037C (zh) 2001-01-03
EP0717614B1 (de) 1998-11-25
DE59407351D1 (de) 1999-01-07
SK280055B6 (sk) 1999-07-12
KR100351748B1 (ko) 2002-12-26
CZ285475B6 (cs) 1999-08-11
US5759575A (en) 1998-06-02
CN1130865A (zh) 1996-09-11
BR9407444A (pt) 1996-04-09
SK33096A3 (en) 1997-03-05
FI961093A0 (fi) 1996-03-08
FI961093A (fi) 1996-03-08
AU7696094A (en) 1995-03-27

Similar Documents

Publication Publication Date Title
ES2126147T3 (es) Granulado efervescente y procedimiento para su preparacion.
ZA933150B (en) Synergistic composition and process for selective weed control.
HK1019202A1 (en) Polyol composition.
ES2121352T3 (es) Tabletas de limpieza polifuncionales, estables a la rotura y al almacenamiento, procedimientos para su obtencion y su empleo.
HUT72970A (en) Risperidone pamoate, pharmaceutical composition containing it and process for their production
ES2068800T1 (es) Preparacion farmaceutica en forma de un comprimido efervescente o de desintegracion o un granulado soluble al instante, y procedimiento para su produccion.
ES2034212T3 (es) Procedimiento para la preparacion de una composicion detergente granulada.
HK1010722A1 (en) Benzoyl guanidines, their production and their use in medicaments
NO960514D0 (no) Substituerte azadioksacykloalkener og deres anvendelse som fungicider
ES2165391T3 (es) Esteres del acido metilfosfonico, procedimiento para su preparacion y su empleo.
TR200100139T2 (tr) İntegrinlerin reseptörlerine bağlanmasını inhibe eden N,N-iki ikameli amitler
DK0673245T3 (da) Farmaceutisk brusepræparat indeholdende ibuprofen og fremgangsmåde til dets fremstilling.
RU96107100A (ru) Шипучий гранулят и способ его получения
ES2130446T3 (es) Sistema terapeutico transdermico que contiene octildodecanol como inhibidor de cristalizacion.
DE69110299D1 (de) Behandlung anstrengungsbedingter pulmonarer blutungen bei tieren.
ES2132430T3 (es) Derivados de la quinolonilcarboxamidocefalosporina y composiciones farmaceuticas que los contienen.
SE8902886A (es)
TH36626A (th) องค์ประกอบใช้ทางปากต่อต้านก้อนหินปูน
SE9304065D0 (sv) New compound

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 717614

Country of ref document: ES